PHYSIOLOGIC AND PHARMACOLOGIC ENHANCEMENT OF FIBRINOLYSIS

被引：73

作者：

PROWSE, CV ^{[1
]}

CASH, JD ^{[1
]}

机构：

[1] SCOTTISH NATL BLOOD TRANSFUS SERV, HEADQUARTERS UNIT, EDINBURGH, SCOTLAND

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1984年 / 10卷 / 01期

关键词：

D O I：

10.1055/s-2007-1004407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：51 / 60

页数：10

共 138 条

[1]

ALLEN RA, 1982, HAEMOSTASIS S1, V11, P21

[2]

ALLENBY F, 1973, LANCET, V2, P1412

[3] ENDOTHELIAL FACTORS IN RELATION TO PERIPHERAL-CIRCULATION IN DIABETICS [J].

ALMER, LO ;

LILJA, B ;

LINDELL, SE ;

NILSSON, IM .

THROMBOSIS RESEARCH, 1980, 20 (02) :231-238

[4]

ANGLESCANO E, 1979, J LAB CLIN MED, V94, P312

[5] FIBRINOLYTIC ACTIVITY OF VEINS DURING PREGNANCY [J].

ASTEDT, B ;

ISACSON, S ;

NILSSON, IM ;

PANDOLFI, M .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1970, 49 (02) :171-&

[6] NO CROSS-REACTION BETWEEN CIRCULATING PLASMINOGEN ACTIVATOR AND UROKINASE [J].

ASTEDT, B .

THROMBOSIS RESEARCH, 1979, 14 (4-5) :535-539

[7] THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].

ASTRUP, T ;

MULLERTZ, S .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351

[8]

BACHMANN F, 1980, 6TH INT C THROMB

[9]

BENETATO G, 1964, STUDII CERC FIZIOL, V9, P39

[10]

BIGGS R, 1947, LANCET, V252, P402

← 1 2 3 4 5 6 7 8 9 10 →